Glenmark Pharmaceuticals
GLENMARK.NS
#2749
Rank
S$6.16 B
Marketcap
$21.86
Share price
0.59%
Change (1 day)
29.48%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): $0.16

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.14. In 2022 the company made an earnings per share (EPS) of $0.51 a decrease over its 2021 EPS that were of $0.64.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.16-68.5%
2022$0.51-20.18%
2021$0.647.13%
2020$0.6025.72%
2019$0.47-22.01%
2018$0.6130.15%
2017$0.47-34.82%
2016$0.7263.09%
2015$0.449.68%
2014$0.40-26.58%
2013$0.550.51%
2012$0.54